• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从人血小板释放的含血小板因子3的脂蛋白颗粒的分离与鉴定

Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.

作者信息

Sandberg H, Andersson L O, Höglund S

出版信息

Biochem J. 1982 Apr 1;203(1):303-11. doi: 10.1042/bj2030303.

DOI:10.1042/bj2030303
PMID:7103943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1158224/
Abstract

Lipid-protein particles with platelet factor 3 measured by the Stypven clotting-time test [Hardisty & Hutton (1966) Br. J. Haematol. 12, 764-776] have been isolated from platelet-release supernatant. Starting material was washed platelets, which were released by treatment with collagen. Purification of the particles from other components in the release material was accomplished by gel filtration on Sepharose CL-4B followed by affinity chromatography on poly-L-lysine-Sepharose CL-4B gel. Chemical characterization showed that the particles were composed of 40% protein, 42% phospholipids, 13% cholesterol and 5% triacylglycerols. The phospholipid composition was 38% phosphatidylcholine, 25% phosphatidylethanolamine, 9% phosphatidylserine, 2% phosphatidic acid and 26% sphingomyelin. No carbohydrate was detected. Electron-microscopic studies revealed the presence of membranous particles with diameters between 70 and 170 nm.

摘要

已从血小板释放上清液中分离出通过Stypven凝血时间试验[哈迪斯蒂和赫顿(1966年),《英国血液学杂志》12卷,764 - 776页]测定的含血小板因子3的脂蛋白颗粒。起始材料是经胶原处理后释放的洗涤血小板。通过在Sepharose CL - 4B上进行凝胶过滤,随后在聚-L-赖氨酸-Sepharose CL - 4B凝胶上进行亲和色谱,从释放材料中的其他成分中纯化这些颗粒。化学表征表明,这些颗粒由40%的蛋白质、42%的磷脂、13%的胆固醇和5%的三酰甘油组成。磷脂组成是38%的磷脂酰胆碱、25%的磷脂酰乙醇胺、9%的磷脂酰丝氨酸、2%的磷脂酸和26%的鞘磷脂。未检测到碳水化合物。电子显微镜研究显示存在直径在70至170纳米之间的膜状颗粒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0f/1158224/4f88f023c27d/biochemj00378-0298-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0f/1158224/a322698597b5/biochemj00378-0299-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0f/1158224/4f88f023c27d/biochemj00378-0298-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0f/1158224/a322698597b5/biochemj00378-0299-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e0f/1158224/4f88f023c27d/biochemj00378-0298-a.jpg

相似文献

1
Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.从人血小板释放的含血小板因子3的脂蛋白颗粒的分离与鉴定
Biochem J. 1982 Apr 1;203(1):303-11. doi: 10.1042/bj2030303.
2
Biochemical characterization of isolated cholesterol-phospholipid particles continuously released from rat and human platelets after activation.
Lab Invest. 1988 Sep;59(3):344-52.
3
Lipid composition of subcellular particles from sheep platelets. Location of phosphatidylethanolamine and phosphatidylserine in plasma membranes and platelet liposomes.绵羊血小板亚细胞颗粒的脂质组成。磷脂酰乙醇胺和磷脂酰丝氨酸在质膜和血小板脂质体中的定位。
Biochim Biophys Acta. 1986 Apr 14;856(2):193-201. doi: 10.1016/0005-2736(86)90028-3.
4
Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3.人血小板中凝血活性的表达:提供血小板因子1和血小板因子3的膜性小泡的释放。
Thromb Res. 1985 Jul 1;39(1):63-79. doi: 10.1016/0049-3848(85)90122-7.
5
Isolation and physicochemical and immunologic characterization of human platelet factor 3.人血小板因子3的分离及其理化和免疫学特性
Thromb Res. 1979;16(5-6):673-87. doi: 10.1016/0049-3848(79)90211-1.
6
Isolation, characterization and chemical composition of the membrane from sheep platelets.
Biochim Biophys Acta. 1981 Dec 7;649(2):229-38. doi: 10.1016/0005-2736(81)90410-7.
7
Platelet membrane involvement in blood coagulation.血小板膜在血液凝固中的作用。
Blood Cells. 1983;9(2):303-17.
8
Vesiculation of platelet plasma membranes. Dilauroylglycerophosphocholine-induced shedding of a platelet plasma membrane fraction enriched in acetylcholinesterase activity.
Biochim Biophys Acta. 1984 Nov 21;778(1):210-8. doi: 10.1016/0005-2736(84)90464-4.
9
Identification of membrane proteins of human blood platelets with a hydrophobic photolabel.利用疏水性光标记物鉴定人血小板的膜蛋白
Biochim Biophys Acta. 1984 Dec 5;778(2):298-304. doi: 10.1016/0005-2736(84)90372-9.
10
Isolation and characterization of platelet membranes prepared by free flow electrophoresis.通过自由流动电泳制备的血小板膜的分离与特性分析。
Methods Enzymol. 1992;215:5-20. doi: 10.1016/0076-6879(92)15048-h.

引用本文的文献

1
The Use of Extracellular Vesicles as a Promising Therapeutic Approach for Pulmonary Diseases.细胞外囊泡作为肺部疾病一种有前景的治疗方法的应用。
Health Sci Rep. 2025 Jun 11;8(6):e70853. doi: 10.1002/hsr2.70853. eCollection 2025 Jun.
2
Extracellular vesicles: novel communicators in lung diseases.细胞外囊泡:肺部疾病的新型通讯者。
Respir Res. 2020 Jul 8;21(1):175. doi: 10.1186/s12931-020-01423-y.
3
Dynamic Nature of Thrombin Generation, Fibrin Formation, and Platelet Activation in Unstable Angina and Non-Q-Wave Myocardial Infarction.

本文引用的文献

1
THE ACTIVATION OF ANTIHEMOPHILIC FACTOR (FACTOR 8) BY ACTIVATED CHRISTMAS FACTOR (ACTIVATED FACTOR9 9).活化的圣诞因子(活化因子IX)对抗血友病因子(因子VIII)的激活作用
Biochemistry. 1964 Nov;3:1720-5. doi: 10.1021/bi00899a022.
2
OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.关于磷脂与凝血酶原激活物形成中某些凝血因子相互作用的观察
Biochim Biophys Acta. 1964 Aug 19;90:436-9. doi: 10.1016/0304-4165(64)90220-x.
3
THROMBOKINASE AS PRIME ACTIVATOR OF PROTHROMBIN: HISTORICAL PERSPECTIVES AND PRESENT STATUS.
不稳定型心绞痛和非Q波心肌梗死中凝血酶生成、纤维蛋白形成及血小板活化的动态特性
J Thromb Thrombolysis. 1995;2(1):57-64. doi: 10.1007/BF01063163.
4
Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".小鼠/人嵌合7E3抗体对血小板介导的、组织因子诱导的凝血酶生成的抑制作用。对c7E3 Fab治疗急性血栓形成和“临床再狭窄”效果的潜在影响。
J Clin Invest. 1996 Aug 1;98(3):863-74. doi: 10.1172/JCI118859.
5
Role of platelets in cholesteryl ester formation by U-937 cells.血小板在U-937细胞形成胆固醇酯过程中的作用。
J Clin Invest. 1988 Jan;81(1):62-8. doi: 10.1172/JCI113311.
6
Role of the membrane skeleton in preventing the shedding of procoagulant-rich microvesicles from the platelet plasma membrane.膜骨架在防止富含促凝剂的微泡从血小板质膜脱落中的作用。
J Cell Biol. 1990 Aug;111(2):483-93. doi: 10.1083/jcb.111.2.483.
作为凝血酶原主要激活剂的凝血激酶:历史回顾与现状
Fed Proc. 1964 Jul-Aug;23:742-8.
4
Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation.细胞化学与电子显微镜术。醛类固定对细胞超微结构及酶活性的保存作用。
J Cell Biol. 1963 Apr;17(1):19-58. doi: 10.1083/jcb.17.1.19.
5
Platelet phosphatides. Their fatty acid and aldehyde composition and activity in different clotting systems.血小板磷脂。它们在不同凝血系统中的脂肪酸、醛类组成及活性。
J Clin Invest. 1962 Dec;41(12):2198-212. doi: 10.1172/JCI104679.
6
Phosphorus assay in column chromatography.柱色谱法中的磷测定
J Biol Chem. 1959 Mar;234(3):466-8.
7
A simple method for the isolation and purification of total lipides from animal tissues.一种从动物组织中分离和纯化总脂质的简单方法。
J Biol Chem. 1957 May;226(1):497-509.
8
Factor Va-dependent binding of factor Xa to human platelets.凝血因子Xa与人类血小板的凝血因子Va依赖性结合。
J Biol Chem. 1980 Feb 10;255(3):1170-4.
9
A study of the reaction product of factor 8 and factor IX by gel filtration.
Thromb Diath Haemorrh. 1967 Aug 15;18(1-2):211-22.
10
Reaction sequence of blood coagulation.血液凝固的反应序列。
Nature. 1967 Sep 9;215(5106):1201-2. doi: 10.1038/2151201a0.